UNION CITY, Calif., July 30 /PRNewswire-FirstCall/ -- ABAXIS, Inc. (Nasdaq: ABAX), a medical products company manufacturing point-of-care blood analysis systems, today reported financial results for the first fiscal quarter ended June 30, 2009.
Record quarterly highlights include:
- Revenues of $29.6 million, up 21% over last year's comparable quarter.
- Veterinary market sales of $21.8 million, up 31% over last year's comparable quarter.
- North America revenues of $24.1 million, up 19% over last year's comparable quarter.
- International revenues of $5.5 million, up 29% over last year's comparable quarter.
- Medical and veterinary reagent disc sales of $18.4 million, up 31% over last year's comparable quarter.
- Gross profit of $17.2 million, up 27% over last year's comparable quarter.
- Operating income of $5.7 million, up 42% over last year's comparable quarter.
- Net income of $3.8 million, up 35% over last year's comparable quarter.
Quarterly Results: For the fiscal quarter ended June 30, 2009, Abaxis reported revenues of $29.6 million, as compared with revenues of $24.6 million for the comparable period last year, an increase of 21 percent. Revenues from instrument sales, which include chemistry analyzers, hematology instruments and coagulation analyzers, decreased by an aggregate of $1.5 million, or 20 percent, over the same period last year. Revenues from consumables, which include reagent discs, hematology reagent kits, coagulation cartridges, i-STAT cartridges and heartworm rapid tests, increased by an aggregate of $6.0 million, or 40 percent, over the same period last year. The company reported net income of $3.8 million, compared to $2.8 milli
'/>"/>
SOURCE Abaxis, Inc. Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 Related medicine news :1.
Abaxis to Report First Quarter Fiscal 2010 Financial Results Thursday, July 30, 20092.
Abaxis, Inc. to Present at Bank of America and Merrill Lynch 2009 Health Care Conference3.
Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 20094.
Abaxis to Report Fourth Quarter Fiscal 2009 Financial Results Wednesday, April 29, 20095.
ABAXIS Realigns North American Medical Sales and Marketing6.
Abaxis, Inc. to Attend Lazard Capital Markets Medical Technologies Conference7.
Abaxis, Inc. to Present at Sidoti & Companys Thirteenth Annual New York Emerging Growth Institutional Investor Forum8.
Abaxis Reports Financial Performance for the Third Quarter of Fiscal 20099.
ABAXIS Announces Launch of Two New Products at the NAVC10.
ABAXIS Announces Contract Manufacturing Agreement with SA Scientific, Ltd.11.
Abaxis, Inc. to Present at Sidoti & Companys Sixth Annual Palm Beach Emerging Growth Institutional Investor Forum